FDA Import Refusal 799-0441418-2/11/1 — Astellas Pharma Europe
The FDA refused shipment 799-0441418-2/11/1 from Astellas Pharma Europe (United Kingdom) on Sep 1, 2022. The refused product falls under Drugs and Biologics — TACROLIMUS (IMMUNOSUPPRESSIVE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 1, 2022
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 64TCB08 TACROLIMUS (IMMUNOSUPPRESSIVE)
- Charges
- 75